Evonetix is a UK biotechnology company developing semiconductor-based DNA synthesis technology, including a platform intended to synthesize highly accurate DNA sequences in parallel. It serves life-science researchers and applications such as synthetic biology, diagnostics, and therapeutic development.
Subscribe to see Evonetix’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
A few of Evonetix's closest competitors — see the full list of competitors and alternatives →
DNA Script develops enzymatic DNA synthesis technology, offering the SYNTAX platform and associated kits that enable laboratories to produce high-quality oligonucleotides in-house and on-demand. The company serves biotech companies, pharmaceutical firms, contract research organizations, core facilities, and governmental agencies seeking to streamline synthetic biology workflows.
DINYA DNA provides a next-generation DNA synthesis platform that utilizes a multi-enzyme process to directly create long and complex double-stranded DNA molecules without requiring traditional oligo assembly. The company serves scientists and researchers by delivering custom DNA sequences with fast turnaround times and minimal complexity limitations.
Synhelix is a French biotechnology company founded in 2019 to develop affordable DNA synthesis technology and address the supply bottleneck of DNA constructs for biotherapeutics development. The company was acquired by Univercells to be incorporated into its affiliate Quantoom, expanding its operations into synthetic biology.
Twist Bioscience Corp is headquartered in South San Francisco, California, and operates in the synthetic biology sector. The company manufactures and sells customized DNA synthesis products utilizing a silicon-based platform for various scientific applications.
Centrillion Technology Holdings Corp. provides a light-directed synthetic biology platform utilizing high-density DNA chips to measure molecular signals at scale. The company generates precise biological data for researchers and AI models to decode genomes, cells, and tissues in spatial biology and genomics applications.
Source BioScience is a UK-based laboratory services company providing genomics, DNA sequencing, molecular diagnostics, and pathology-related testing. It serves pharmaceutical and biotechnology companies, healthcare organizations, research institutions, and other life-science customers.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.